Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

284.70
Delayed Data
As of Jul 24
 +1.78 / +0.63%
Today’s Change
244.28
Today|||52-Week Range
307.33
+8.99%
Year-to-Date

Today’s Trading

Previous close282.92
Today’s open283.00
Day’s range280.01 - 285.35
Volume1,476,166
Average volume (3 months)1,578,614
Market cap$60.0B
Dividend yield--
Data as of 07/24/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+0.88%
Earnings growth (next 5 years)+5.80%
Revenue growth (last year)+9.37%
P/E ratio17.8
Price/Sales6.09
Price/Book5.03

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+1.24+0.72%
GILDGilead Sciences+0.63+0.85%
BIVVBioverativ Inc+0.40+0.63%
KITEKite Pharma Inc+3.83+3.51%
Data as of 07/24/2017

Financials

Last reporting dateJuly 25, 2017
EPS forecast (this quarter)$4.53
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
VP-Finance, Chief Financial &
Accounting Officer
Gregory F. Covino
Corporate headquarters
Cambridge, Massachusetts

Forecasts